Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01493362 · ClinicalTrials.gov registry record
Imaging the Dopamine Systems in Bulimia Nervosa
A clinical trial of Eating Disorders, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 33
- Enrollment target
- 1
- Study location
NCT01493362: Completed study of Eating Disorders, sponsored by New York State Psychiatric Institute.
NCT01493362 is a study of Eating Disorders that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 33 participants, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01493362, a study of Eating Disorders, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use positron emission tomography imaging to investigate the dopamine systems in people with bulimia nervosa.
Conditions Studied
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-12 |
What the finished NCT01493362 record still lists
NCT01493362 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 322-participant average among 37 other Eating Disorders trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Eating Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT01493362 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01493362 about?
NCT01493362 is a clinical study titled "Imaging the Dopamine Systems in Bulimia Nervosa". This study will use positron emission tomography imaging to investigate the dopamine systems in people with bulimia nervosa.
What is the current status of trial NCT01493362?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2008-01. Estimated completion is 2013-12.
What conditions does trial NCT01493362 study?
This clinical trial studies the following conditions: Eating Disorders.
Who is sponsoring clinical trial NCT01493362?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01493362 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01493362's enrollment target sits among peer trials
33 31st of 37 higher than 7 of 37 other Eating Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eating Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Diabetes Body Project 2
RECRUITING · NA
-
Acceptability and Feasibility of a Single-Session Online Parent-Focused Intervention Targeting Child Body Image Development
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia